Disease Information & Support


The Word:


Generic name Deferoxamine mesylate
Pronunciation de-fer-OX-sa-meen ME-sil-ate
Brand name(s), other common name(s) Desferal®, DFO
Drug type  Iron chelator
How the drug is given Intramuscular (IM) or subcutaneous (SC) injection; may be given intravenously (IV)

Deferoxamine mesylate is FDA approved to treat people who have acute iron intoxication and of chronic iron overload due to transfusion-dependent anemia.

Side effects needing medical attention: Hearing loss; vision problems; decrease in urination; fever; unusual bleeding or bruising; lack of energy; loss of appetite; pain in the upper right part of the stomach; yellowing of the skin or eyes; hives; rash; difficulty breathing or swallowing; swelling of the face, throat, tongue, lips, eyes, hands, feet or ankles.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012